Vindhya Data Science
Vindhya Data Science is a women-owned professional services firm providing bioinformatics, genomics, and machine learning analytics to federal government agencies, academic medical centers, and pharma/biotech companies for drug discovery, biomarker development, and clinical trial data analysis.
- Company typePrivate
- Founded2021
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Vindhya Data Science does
Vindhya Data Science, Inc. is a women-owned small business founded in 2021 and headquartered in Research Triangle Park, North Carolina, with a secondary office in Boston. The company operates as a specialized data science professional services firm serving healthcare and life sciences clients, with domain focus on evidence-based medicine, epidemiology, bioinformatics, genomics, machine learning, and structural biology. Its clientele spans federal government health agencies, leading academic medical centers, and pharmaceutical/biotech companies, for whom it executes engagements ranging from small-scale analyses to large-scale, multi-year collaborations.
Technically, Vindhya delivers drug discovery support (drug target identification, biomarker discovery for patient stratification, resistance mechanism identification, high-throughput screen analysis including CRISPR, RNAi and drug perturbation, and histology image analysis), genomic analyses (RNA-seq from bulk and single-cell samples, DNA-seq variant identification, immune repertoire sequencing, cell-free DNA tumor fraction estimation, and multi-omics integration), and software development on Google Cloud and AWS. It has built proprietary platforms including PrismML (a machine learning platform for genomics), BIOSuite (an end-to-end digital platform for biomarker trials presented at BioIT World 2024), and vmup (an open-source single-binary terminal UI GCP instance manager that provisions VMs via Terraform and opens SSH tunnels over Identity-Aware Proxy, distributed on GitHub under Apache-2.0).
The business model is primarily professional services consulting billed on a custom, quote-based, project-by-project basis (no publicly disclosed pricing), supplemented by proprietary software platform development and deployment. Go-to-market is relationship-driven and reputation-led, anchored in scientific publications (150+ combined), conference presentations (BioIT World, AACR, SLAS), and direct enterprise engagement rather than a scaled sales motion. The company reports 100+ years of combined team experience and 73+ completed projects, and remains founder-owned with no disclosed external funding.
Vindhya Data Science firmographics
Firmographics- Name
- Vindhya Data Science
- Legal name
- Vindhya Data Science, Inc.
- Website
- https://vindhyadatascience.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Vindhya Data Science is a women-owned professional services firm providing bioinformatics, genomics, and machine learning analytics to federal government agencies, academic medical centers, and pharma/biotech companies for drug discovery, biomarker development, and clinical trial data analysis.
- Ownership category
- akta.pro rank
Vindhya Data Science industry classification
Industry- Product category
- Bioinformatics and Genomics Data Analytics Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Software Publishers (51321)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
- akta.pro secondary industry
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
Keywords
Where Vindhya Data Science is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Vindhya Data Science business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Data Science Consulting Services: Professional services engagements for drug discovery, genomic analyses, and bioinformatics projects. Services range from small-scale analysis to large-scale, multi-year collaborations with federal government, academic medical centers, and pharma/biotech clients.
- Software Platform Licensing: Development and deployment of proprietary software platforms such as PrismML for genomics and BIOSuite for biomarker trials. Revenue derived from platform development and deployment services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Vindhya Data Science product offering
Product offeringCore offering
Vindhya Data Science is a women-owned data science firm that delivers professional services and proprietary software for evidence-based medicine, bioinformatics, genomics, and machine learning. It engages in project-based collaborations with federal government agencies, academic medical centers, and pharma/biotech companies, ranging from small-scale analyses to large, multi-year programs. Its proprietary platforms include PrismML (machine learning for genomics), BIOSuite (digital biomarker trial solutions), and vmup (open-source GCP instance manager).
Product overview
Vindhya Data Science offers a portfolio of specialized data science products and services centered on evidence-based medicine, epidemiology, bioinformatics, and genomics. The primary technology products are vmup (a GCP instance manager built as a single-binary TUI with embedded Terraform and IAP-based access), PrismML (a machine learning platform deployed for genomics analysis), and BIOSuite (an end-to-end digital platform for biomarker trials). These are complemented by a range of scientific services spanning drug discovery, genomic analyses, and software development.
Differentiator
Problem solved
Functional benefit
Brands
- vmup: GCP Instance Manager - A single-binary TUI for launching and managing Google Cloud compute instances. Provisions VMs with Terraform, opens SSH tunnels over IAP, and provides an interactive terminal UI.
- PrismML
- BIOSuite
Products and services
- Drug Discovery Services
- Genomic Analyses Services
- Software Development Services
- PrismML A proprietary machine learning platform developed and deployed by Vindhya for genomics analysis, enabling clients to build and run ML models on genomic data for applications such as biomarker discovery and patient stratification.
- BIOSuite An end-to-end digital solutions platform for biomarker trials, enabling digital management and analysis of biomarker data across clinical trial workflows. Introduced by Dr. Alex V. Nesta and Dr. Anupama Reddy at BioIT World 2024.
- vmup A single-binary terminal user interface (TUI) for launching and managing Google Cloud Platform compute instances. Provisions VMs with embedded Terraform, opens SSH tunnels over Identity-Aware Proxy (IAP), and provides an interactive UI for full VM lifecycle management including persistent data disks, tunnel management, and live cost estimates from the Cloud Billing API. Distributed as open-source via GitHub under Apache-2.0 license.
Quantifiable outcome
- 100+ years of combined experience across the team
- +2 more outcomes
Companies that use Vindhya Data Science
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Vindhya Data Science technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability5 records
Feature4 records
Vindhya Data Science partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Vanderbilt University (Dr. Scott Haake, Dr. Joseph Vento, Dr. Katy Beckermann)coreResearch collaboration on spatial biology and AI-based biomarkers for kidney cancer patients, presented at AACR 2024 conference.
- Federal GovernmentcoreOngoing partnerships with federal government agencies for data science and analytics projects in healthcare and life sciences.
- Leading Academic Medical CenterscoreOngoing partnerships with academic medical centers for collaborative research in bioinformatics, genomics, and data science applications in healthcare.
- Pharma/Biotech CompaniescoreOngoing partnerships with pharmaceutical and biotechnology companies for drug discovery, biomarker development, and clinical trial data analysis projects.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
Vindhya Data Science competitors and assessment
Company assessmentDirect peers
- Genedata: Enterprise bioinformatics platform and scientific data management vendor serving pharma R&D and translational science — directly comparable to Vindhya’s PrismML/BIOSuite vision for biomarker workflows.
- Champions Oncology: Preclinical/clinical CRO with bioinformatics and biomarker discovery services for pharma; comparable scale-stage services firm serving similar translational use cases.
- DNAnexus: Cloud-based genomics and biomedical data-analysis platform used by pharma and clinical labs; competes in the same ‘omics data management and analysis category as PrismML.
- Seven Bridges Genomics (Velsera): Bioinformatics platform and services for precision genomics, including NIH NCI Cancer Genomic Cloud; directly comparable to Vindhya’s genomics analysis and federal health-agency work.
Broad incumbents
- Tempus Labs: AI-enabled precision medicine data platform spanning multi-omics, clinical, and imaging analytics; broad incumbent in the same precision-medicine data category Vindhya serves.
- Flatiron Health: Oncology-focused real-world data and clinical analytics platform acquired by Roche; comparable as an established health-data/biomarker analytics incumbent serving biopharma.
- QIAGEN Digital Insights (formerly QDI/QCI): Established bioinformatics and clinical genomics interpretation provider with deep pharma/biotech reach; overlaps with Vindhya’s variant, RNA-seq, and biomarker interpretation services.
- Medidata Solutions (Dassault Systèmes): Clinical-trial data and analytics platform; broadly comparable as incumbent infrastructure for biomarker and ‘omics workflows in pharma trials.
Others
- Open Health Science / AHRQ-aligned analytics contractors: Ecosystem counterpart for the federal comparative-effectiveness and oral-health research publishing work that Vindhya executes (AHRQ rapid reviews).
Emerging players
- Berry Genomics (biomarker/CRO peers) — e.g., Cofactor Genomics: Specialized immuno-oncology biomarker and immune-repertoire analytics CRO; comparable emerging peer in the immune-repertoire and biomarker-discovery services niche.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights7 records
Customer concentration
Vindhya Data Science social profiles
Digital presenceVindhya Data Science financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vindhya Data Science leadership team
Management profileNumber of profiles
Profiles2 records
Vindhya Data Science funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vindhya Data Science M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vindhya Data Science
What does Vindhya Data Science do?
Vindhya Data Science is a women-owned data science firm that delivers professional services and proprietary software for evidence-based medicine, bioinformatics, genomics, and machine learning. It engages in project-based collaborations with federal government agencies, academic medical centers, and pharma/biotech companies, ranging from small-scale analyses to large, multi-year programs. Its proprietary platforms include PrismML (machine learning for genomics), BIOSuite (digital biomarker trial solutions), and vmup (open-source GCP instance manager).
Is Vindhya Data Science a public or private company?
Vindhya Data Science is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vindhya Data Science founded?
Vindhya Data Science was founded in 2021. It employs 1 to 10 people.
Where is Vindhya Data Science based?
Vindhya Data Science is headquartered in Boston, United States, in the North America region.
How does Vindhya Data Science make money?
Two revenue lines are on record. Data Science Consulting Services are the primary driver. The others are software Platform Licensing.
Who are Vindhya Data Science's main competitors?
Direct peers on record are Genedata, Champions Oncology, DNAnexus and Seven Bridges Genomics (Velsera). Broad incumbents are Tempus Labs, Flatiron Health, QIAGEN Digital Insights (formerly QDI/QCI) and Medidata Solutions (Dassault Systèmes). Open Health Science / AHRQ-aligned analytics contractors is listed as an others. Berry Genomics (biomarker/CRO peers) — e.g., Cofactor Genomics is listed as an emerging player.
Does Vindhya Data Science have an API?
No public API is recorded for Vindhya Data Science.
What industry is Vindhya Data Science in?
Vindhya Data Science's product category is Bioinformatics and Genomics Data Analytics Services. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 54171 and its SIC code is 8731.